Moxifloxacin: safety profile
The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
Главный автор: | A. I. Sinopalnikov |
---|---|
Формат: | Статья |
Язык: | Russian |
Опубликовано: |
Remedium Group LLC
2013-12-01
|
Серии: | Медицинский совет |
Предметы: | |
Online-ссылка: | https://www.med-sovet.pro/jour/article/view/1152 |
Схожие документы
-
Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
по: A. A. Bobylev, и др.
Опубликовано: (2014-12-01) -
Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
по: A. I. Sinopalnikov
Опубликовано: (2014-12-01) -
Rational therapy of patients with lower respiratory tract infections
по: V. A. Kazantsev
Опубликовано: (2013-12-01) -
Cough in children as a symptom of respiratory tract infections: a new look at the problem of antibiotic therapy
по: O. A. Egorova
Опубликовано: (2014-12-01) -
Местная иммуномодуляция при заболеваниях верхних дыхательных путей
Опубликовано: (2018-06-01)